Skip to main content
. 2016 Sep 23;60(10):6146–6154. doi: 10.1128/AAC.01024-16

TABLE 1.

In vitro antimicrobial activities of ceftriaxone, azithromycin, or their combination against S. pneumoniae strains 741 and ATCC 49619

Strain MIC (μg/ml)
FICIa
Ceftriaxone Azithromycin Ceftriaxone-azithromycin combination (ceftriaxone MIC/azithromycin MIC)
741 0.5 2 0.25/1 1
ATCC 49619b 0.062 0.125 0.015/0.062 0.75
a

The results were interpreted as follows: FICI ≤ 0.5, synergy; 0.5 < FICI ≤ 4, no interaction; and FICI > 4, antagonism.

b

S. pneumoniae strain ATCC 49619 was used as a quality control strain.